BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KIT2014 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of KIT2014\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07668518-1544@assetmemo.bio
DTSTAMP:20261121T004521Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:KIT2014: Phase 1/2 readout est. (NCT07668518)
DESCRIPTION:KIT2014\, phase 1/2\, Chronic Obstructive Pulmonary Disease.\nS
 tudy: A Study of the Safety\, Tolerability\, Pharmacokinetics and Efficacy
  of KIT2014 in Patients With Moderate to Severe COPD\nEstimated primary co
 mpletion: 31 March 2027. This is a ClinicalTrials.gov estimate\, not a con
 firmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/d
 rug/kit2014#upcoming-events\nRegistry record: https://clinicaltrials.gov/s
 tudy/NCT07668518
URL:https://assetmemo.bio/drug/kit2014#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
